Product Overview Product feature summary

• This product has not been FDA cleared or approved, but has been authorized by FDA under an EUA for use by authorized laboratories.

• This product has been authorized only for the detection of proteins from SARS-CoV-2, influenza A and influenza B, not for any other viruses or pathogens.

• The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

Specifications Product specifications and dimensions

• Additional Attributes
  Analyzer
• Brand
  Veritor Plus
• CLIA Classification
  CLIA Waived
• Item
  Kit
• Item Type
  COVID-19/Flu A&B
• Quantity
  Each

Catalog Description As seen in our print catalog

Point-of-care testing for SARS-CoV-2, Flu A+B, RSV (respiratory syncytial virus), and Group A Strep, providing rapid diagnostic testing in a convenient, portable instrument. One-button functionality and workflow flexibility allow the health-care team to confidently use the device. In addition, the system’s fast and reliable results may help improve the patient experience. The system streamlines the point-of-care testing experience, stores or downloads the lot number, patient/specimen ID, operator ID, and test records using the BD Veritor™ InfoWiFi module or via the companion ImageMover application.